Create
Query
event_store.db
—
signals
actions
approvals
artifacts
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row sig_5a5cfb6e1929 in signals
id
sig_5a5cfb6e1929
Primary key.
TEXT
event_id
8241
TEXT NOT NULL
watcher_id
NULL
TEXT
signal_type
news_headline_delta
TEXT NOT NULL
value
{"aggregator_url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPWEFmeV9vdEJMLV9aTnpUakJaaTg2Vkd0X0FwNllhYmlRelBldlBndWdvb3Rta1RTcjI5RWdIVHdwNnRDd3RkQldEdlRiZWp4TGdlbVFjSFpUZEExMHQ1Qmx2LS12cUVzR1dMZFJWY0oyU0pySmZBcXREbkVIQ2pncVRkV29hRVYzVkh1NGNVWDV6cy1RTXpMMmZoVFJKQjJyUmRv?oc=5","as_of":"2026-04-08T19:34:52.395599+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPWEFmeV9vdEJMLV9aTnpUakJaaTg2Vkd0X0FwNllhYmlRelBldlBndWdvb3Rta1RTcjI5RWdIVHdwNnRDd3RkQldEdlRiZWp4TGdlbVFjSFpUZEExMHQ1Qmx2LS12cUVzR1dMZFJWY0oyU0pySmZBcXREbkVIQ2pncVRkV29hRVYzVkh1NGNVWDV6cy1RTXpMMmZoVFJKQjJyUmRv?oc=5","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_06b52a0a7cd80b2e","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-09T22:06:15.133521+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPWEFmeV9vdEJMLV9aTnpUakJaaTg2Vkd0X0FwNllhYmlRelBldlBndWdvb3Rta1RTcjI5RWdIVHdwNnRDd3RkQldEdlRiZWp4TGdlbVFjSFpUZEExMHQ1Qmx2LS12cUVzR1dMZFJWY0oyU0pySmZBcXREbkVIQ2pncVRkV29hRVYzVkh1NGNVWDV6cy1RTXpMMmZoVFJKQjJyUmRv?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"nb.com","publisher_resolution":"payload_source_domain","requested_url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPWEFmeV9vdEJMLV9aTnpUakJaaTg2Vkd0X0FwNllhYmlRelBldlBndWdvb3Rta1RTcjI5RWdIVHdwNnRDd3RkQldEdlRiZWp4TGdlbVFjSFpUZEExMHQ1Qmx2LS12cUVzR1dMZFJWY0oyU0pySmZBcXREbkVIQ2pncVRkV29hRVYzVkh1NGNVWDV6cy1RTXpMMmZoVFJKQjJyUmRv?oc=5","source_event_id":"evt_f9ba3f980503","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"d9a89655a3648bf8","published_at":"2026-04-08T15:49:33+00:00","publisher_domain":"nb.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.62,"dates_mentioned":[],"entities":[{"asset_class":"equity","name":"Neuberger Berman","relevance":"primary source/publisher","symbol":"","type":"company"},{"asset_class":"healthcare/biopharma (therapy)","name":"Oral GLP-1","relevance":"core subject of the headline","symbol":"","type":"product/therapy class"}],"event_type":"other","information_gaps":["No article body content was provided beyond styling/HTML, so the specific arguments, companies mentioned, and any market/credit metrics are unknown.","No explicit timing (e.g., launch date, market reaction date) is stated in the provided text.","No specific credit instruments, issuers, or tickers are identified in the provided text."],"key_facts":["The headline states: \"Oral GLP-1 Is Here.\"","The headline states: \"Have Credit Markets Caught Up?\"","The source is attributed to Neuberger Berman (nb.com)."],"numeric_claims":[],"primary_claim":"Oral GLP-1 is now available, and the article asks whether credit markets have caught up.","relevance_score":0.45,"sentiment":"neutral","source_quality":"high","summary":"Neuberger Berman discusses the arrival of oral GLP-1 therapies and questions whether credit markets have already adjusted to the implications.","topics":["oral GLP-1","credit markets","market pricing/adjustment","credit risk/financing implications"]},"source":"Neuberger Berman","source_domain":"nb.com","source_url":"https://www.nb.com","summary":"Oral GLP-1 Is Here. Have Credit Markets Caught Up? Neuberger Berman","title":"Oral GLP-1 Is Here. Have Credit Markets Caught Up? - Neuberger Berman","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp"}
TEXT NOT NULL
threshold
NULL
TEXT
direction
NULL
TEXT
severity
NULL
TEXT
window
NULL
TEXT
source
news_rss
TEXT NOT NULL
reason_trace
{"_evidence_event_ids":["evt_f9ba3f980503"]}
TEXT
dedupe_key
signal_enriched:news_delta:36fc0fa41dc4a437
TEXT NOT NULL
throttle_s
INTEGER (default 0
created_at
2026-04-08T19:34:52.395599+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel